ClinicalTrials.gov
ClinicalTrials.gov Menu

Carboplatin-based Chemotherapy With or Without Panitumumab in Platinum-sensitive Recurrent Ovarian Cancer (PROVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01388621
Recruitment Status : Unknown
Verified August 2013 by WiSP Wissenschaftlicher Service Pharma GmbH.
Recruitment status was:  Recruiting
First Posted : July 6, 2011
Last Update Posted : August 20, 2013
Sponsor:
Collaborator:
ClinAssess GmbH
Information provided by (Responsible Party):
WiSP Wissenschaftlicher Service Pharma GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2014
  Estimated Study Completion Date : July 2015